Cyclopentobarbital
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-
diazinane-2,4,6-trione |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 76-68-6 302-34-1 (sodium salt) |
ATC code | None |
PubChem | CID 6454 |
ChemSpider | 6212 |
Synonyms | Allylpental, Cyclopental, 5-Allyl-5-Δ2-Cyclopentenyl Barbituric Acid |
Chemical data | |
Formula | C12H14N2O3 |
Molar mass | 234.251 g/mol |
|
|
|
|
(verify) |
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s.[1] It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
See also[edit]
References[edit]
- ^ Martin, J. R.; Godel, T.; Hunkeler, W.; Jenck, F.; Moreau, J.-L.; Sleight, A. J.; Widmer, U. (2000). "Psychopharmacological Agents". doi:10.1002/0471238961.1619250313011820.a01.
- ^ Vander Brook MJ, Cartland GF. A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal). Journal of Pharmacology And Experimental Therapeutics, 1944, 80(2): 119-125
This sedative-related article is a stub. You can help Wikipedia by expanding it. |